Search

Your search keyword '"Rivellese, A. A."' showing total 63 results

Search Constraints

Start Over You searched for: Author "Rivellese, A. A." Remove constraint Author: "Rivellese, A. A." Database OAIster Remove constraint Database: OAIster
63 results on '"Rivellese, A. A."'

Search Results

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.

3. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.

4. MUSTANG: Multi-Stain Self-Attention Graph Multiple Instance Learning Pipeline for Histopathology Whole Slide Images

5. Automated segmentation of rheumatoid arthritis immunohistochemistry stained synovial tissue

6. Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.

7. EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology.

8. Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT

9. EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology

10. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.

11. Dietary fat intakes and cardiovascular disease risk in adults with type 2 diabetes : a systematic review and meta-analysis

12. EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future

13. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

14. Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study

15. B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure.

16. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake

17. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake

18. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

19. Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study

20. Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis

21. Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study

22. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

23. Perspective:Essential study quality descriptors for data from nutritional epidemiologic research

24. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men

25. Perspective:Essential study quality descriptors for data from nutritional epidemiologic research

26. CONTROVERSIAL ROLES OF MAST CELLS IN RHEUMATOID ARTHRITIS

27. CONTROVERSIAL ROLES OF MAST CELLS IN RHEUMATOID ARTHRITIS

28. Metabolic transformations of dietary polyphenols : comparison between in vitro colonic and hepatic models and in vivo urinary metabolites

29. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men

30. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

31. Whole-grain wheat consumption reduces inflammation in a randomized controlled trial on overweight and obese subjects with unhealthy dietary and lifestyle behaviors: role of polyphenols bound to cereal dietary fiber

32. Phenolic metabolites as compliance biomarker for polyphenol intake in a randomized controlled human intervention

33. Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk

34. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial

35. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial

36. Impact of postprandial glycaemia on health and prevention of disease

37. Impact of postprandial glycaemia on health and prevention of disease

38. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol : The KANWU Study

39. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study

40. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study

41. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study

42. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people : Is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

43. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

44. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

45. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

46. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

47. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

48. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans

50. Effects of dietary saturated, monounsaturated and n-3 fatty acids on blood pressure in healthy subjects

Catalog

Books, media, physical & digital resources